• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类心脏类器官损伤模型的建立揭示了先天性再生潜力。

Development of a human cardiac organoid injury model reveals innate regenerative potential.

作者信息

Voges Holly K, Mills Richard J, Elliott David A, Parton Robert G, Porrello Enzo R, Hudson James E

机构信息

School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland 4072, Australia.

Murdoch Children's Research Institute, Royal Children's Hospital, School of Biosciences, The University of Melbourne, Parkville, Victoria 3052, Australia.

出版信息

Development. 2017 Mar 15;144(6):1118-1127. doi: 10.1242/dev.143966. Epub 2017 Feb 7.

DOI:10.1242/dev.143966
PMID:28174241
Abstract

The adult human heart possesses a limited regenerative potential following an ischemic event, and undergoes a number of pathological changes in response to injury. Although cardiac regeneration has been documented in zebrafish and neonatal mouse hearts, it is currently unknown whether the immature human heart is capable of undergoing complete regeneration. Combined progress in pluripotent stem cell differentiation and tissue engineering has facilitated the development of human cardiac organoids (hCOs), which resemble fetal heart tissue and can be used to address this important knowledge gap. This study aimed to characterize the regenerative capacity of immature human heart tissue in response to injury. Following cryoinjury with a dry ice probe, hCOs exhibited an endogenous regenerative response with full functional recovery 2 weeks after acute injury. Cardiac functional recovery occurred in the absence of pathological fibrosis or cardiomyocyte hypertrophy. Consistent with regenerative organisms and neonatal human hearts, there was a high basal level of cardiomyocyte proliferation, which may be responsible for the regenerative capacity of the hCOs. This study suggests that immature human heart tissue has an intrinsic capacity to regenerate.

摘要

成人心脏在缺血事件后具有有限的再生潜力,并会对损伤产生一系列病理变化。尽管斑马鱼和新生小鼠心脏中已记录到心脏再生,但目前尚不清楚未成熟的人类心脏是否能够完全再生。多能干细胞分化和组织工程的联合进展促进了人类心脏类器官(hCOs)的发展,其类似于胎儿心脏组织,可用于填补这一重要的知识空白。本研究旨在表征未成熟人类心脏组织对损伤的再生能力。在用干冰探针进行冷冻损伤后,hCOs在急性损伤后2周表现出内源性再生反应并实现完全功能恢复。心脏功能恢复发生在无病理性纤维化或心肌细胞肥大的情况下。与再生生物和新生人类心脏一致,心肌细胞增殖的基础水平较高,这可能是hCOs具有再生能力的原因。本研究表明,未成熟的人类心脏组织具有内在的再生能力。

相似文献

1
Development of a human cardiac organoid injury model reveals innate regenerative potential.人类心脏类器官损伤模型的建立揭示了先天性再生潜力。
Development. 2017 Mar 15;144(6):1118-1127. doi: 10.1242/dev.143966. Epub 2017 Feb 7.
2
Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish.斑马鱼心脏冷冻损伤后再生过程中的广泛瘢痕形成和消退。
Development. 2011 May;138(9):1663-74. doi: 10.1242/dev.060897. Epub 2011 Mar 23.
3
Neonatal Heart Regeneration: Comprehensive Literature Review.新生儿心脏再生:全面文献综述。
Circulation. 2018 Jul 24;138(4):412-423. doi: 10.1161/CIRCULATIONAHA.118.033648.
4
Differential regenerative capacity of neonatal mouse hearts after cryoinjury.冷冻损伤后新生小鼠心脏的差异再生能力。
Dev Biol. 2015 Mar 1;399(1):91-99. doi: 10.1016/j.ydbio.2014.12.018. Epub 2014 Dec 31.
5
Cryoinjury Model for Tissue Injury and Repair in Bioengineered Human Striated Muscle.生物工程化人横纹肌组织损伤与修复的冷冻损伤模型
Methods Mol Biol. 2017;1668:209-224. doi: 10.1007/978-1-4939-7283-8_15.
6
Building and re-building the heart by cardiomyocyte proliferation.通过心肌细胞增殖构建和重塑心脏。
Development. 2016 Mar 1;143(5):729-40. doi: 10.1242/dev.132910.
7
Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.人类心脏类器官中的功能筛选揭示了心肌细胞细胞周期停滞的代谢机制。
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8372-E8381. doi: 10.1073/pnas.1707316114. Epub 2017 Sep 15.
8
Persistent scarring and dilated cardiomyopathy suggest incomplete regeneration of the apex resected neonatal mouse myocardium--A 180 days follow up study.持续性瘢痕形成和扩张型心肌病提示新生小鼠心肌切除术后心尖部再生不完全——一项180天随访研究。
J Mol Cell Cardiol. 2016 Jan;90:47-52. doi: 10.1016/j.yjmcc.2015.11.031. Epub 2015 Nov 30.
9
GATA4 regulates Fgf16 to promote heart repair after injury.GATA4调节Fgf16以促进损伤后心脏修复。
Development. 2016 Mar 15;143(6):936-49. doi: 10.1242/dev.130971. Epub 2016 Feb 18.
10
Application of Stem Cell Technologies to Regenerate Injured Myocardium and Improve Cardiac Function.干细胞技术在再生受损心肌及改善心脏功能方面的应用。
Cell Physiol Biochem. 2019;53(1):101-120. doi: 10.33594/000000124.

引用本文的文献

1
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
2
Application of human cardiac organoids in cardiovascular disease research.人类心脏类器官在心血管疾病研究中的应用。
Front Cell Dev Biol. 2025 Mar 31;13:1564889. doi: 10.3389/fcell.2025.1564889. eCollection 2025.
3
Novel organoid model in drug screening: Past, present, and future.药物筛选中的新型类器官模型:过去、现在与未来。
Liver Res. 2021 May 27;5(2):72-78. doi: 10.1016/j.livres.2021.05.003. eCollection 2021 Jun.
4
Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.用于心血管疾病的工程化心脏类器官的模型构建及临床治疗潜力
Biomater Transl. 2024 Nov 15;5(4):337-354. doi: 10.12336/biomatertransl.2024.04.002. eCollection 2024.
5
Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases.革新心血管研究:类器官作为理解和治疗心血管疾病的希望之光。
Mater Today Bio. 2024 Dec 9;30:101396. doi: 10.1016/j.mtbio.2024.101396. eCollection 2025 Feb.
6
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity.L型钙离子通道的药理学或基因抑制通过抑制钙调神经磷酸酶活性促进心肌细胞增殖。
NPJ Regen Med. 2025 Jan 11;10(1):1. doi: 10.1038/s41536-025-00389-z.
7
In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.心血管疾病的体外模型:胚状体、类器官及二者之间的一切。
Biomedicines. 2024 Nov 27;12(12):2714. doi: 10.3390/biomedicines12122714.
8
Multicellular 3D models to study myocardial ischemia-reperfusion injury.用于研究心肌缺血再灌注损伤的多细胞3D模型。
Front Cell Dev Biol. 2024 Nov 15;12:1494911. doi: 10.3389/fcell.2024.1494911. eCollection 2024.
9
Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications.基于三维 iPSC 的体外心脏模型在生物医学和药物研发中的应用。
Int J Mol Sci. 2024 Oct 4;25(19):10690. doi: 10.3390/ijms251910690.
10
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.下一代疗法:利用诱导多能干细胞、基因组学、人工智能以及体外临床试验开拓药物研发。
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.